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ABSTRACT: Hemolysis is the rupture of red blood cells and constitutes the most
common reason for unsuitable blood samples in the clinic. To detect hemolysis, one
has to separate the hemoglobin in blood plasma from that in red blood cells.
However, current methods entail centrifugation for cell-plasma separation, which is
complex, time-consuming, and not easy to integrate into point-of-care (PoC)
systems. Here, we demonstrate an optoﬂuidic sensor composed of nanoﬁlters on an
optical waveguide, which enables evanescent-wave absorption measurement of
hemoglobin in plasma with the capability of real-time inline detection on whole
blood without extra sample preparation like centrifugation. Long-term testing with
inline integration in a modiﬁed, commercial blood gas analyzer shows high reliability
and repeatability of the measurements even with the presence of interference from
bilirubin. We envision that the present work has large potential in improving
diagnosis quality by enabling PoC hemolysis detection in blood gas analyzers and
can also lend unique sensing capabilities to other applications dealing with complex turbid media.
KEYWORDS: hemolysis sensor, Point-of-Care, whole blood, optoﬂuidics, nanowells, waveguide sensor, nanoimprint, in vitro diagnostics
Hemolysis is the rupture of the red blood cells (RBCs) andthe release of their contents into blood plasma.1 It is the
largest preanalytical error source in health care facilities and
clinical laboratories around the world, accounting for 39−69%
of all the unsuitable samplesabout ﬁve times higher than the
second leading cause.2 Hemolysis can originate from both in
vivo conditions, such as sickle cell disease and infections, as well
as in vitro conditions, such as traumatic blood draw and sample
mishandling; the possibility of both occurring complicates
identiﬁcation of the source of hemolysis. Furthermore, the
presence of hemolysis interferes with the detection of
important vital parameters like K+ and Ca+ concentration in
the blood.1 In other situations like cardiac surgery undergoing
cardiopulmonary bypass (CPB), hemolysis is nearly ubiqui-
tous,3 eventually causing acute kidney injury.4 The state-of-the
art hemolysis detection protocols require centrifugation steps
to separate blood plasma and cells, which is time-consuming,
resource demanding, and prone to cause additional preanalyt-
ical errors. Centrifugation protocols are not easy to integrate
into PoC platforms.
In this paper, we present a PoC hemolysis sensor combining
evanescent absorption detection and local plasma separation
without the need of any sample preparation. The plasma
separation is achieved with an integrated nanoﬁlter comprising
an array of nanowells. So far, waveguide absorption spectros-
copy has been demonstrated for sensing pH value,5 protein,6−9
and molecules.10−15 Separation of blood plasma and RBCs is
achieved by either active methods, such as magnetic,16,17
dielectrophoretic,18,19 and acoustic,20,21 or passive methods,
such as hydrodynamic,22−24 sedimentation,25,26 and ﬁltra-
tion.27−30 Our optoﬂuidic strategy is based on an innovative
dual function of nanoﬁlters that act as a component of the
waveguide as well as a functional ﬁlter for RBCs. The
nanoﬁlters enable light propagation without diﬀraction and
scattering while eﬀectively blocking cells or platelets with short
diﬀusion length and time, as shown schematically in Figure 1a.
Grating couplers are integrated to couple broadband LED light
intoand spectrally disperse light out ofthe waveguide
sensor, enabling spectral analysis without using an extra
spectrometer or monochromator. The wavelength range of
the LED light source is adjusted to the highest optical
absorption of Hb, as shown in Figure 1b (highlighted area).
The absorbance measured with the optoﬂuidic sensor is
compared with photospectrometer reference data. The sensor
was integrated into a modiﬁed, commercial blood gas analyzer
(ABL90 FLEX, Radiometer Medical ApS, Denmark), as shown
in Figure 1c, to assess its repeatability, reliability, and durability.
■ RESULTS AND DISCUSSION
Sensor Design and Optical Simulation. The sensor is
designed to have dual-function: a waveguide and a ﬁlter for
RBCs. The waveguide is made by the assembly of a cladding
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layer, a waveguide core layer, and a structured top layer for
ﬁltering. To eﬀectively and reliably eliminate the absorption
from the RBCs (smallest feature size of about 1−2 μm), these
nanoﬁlters have a pitch width of 400 nm and an opening of 200
nm for blood plasma/light interaction. Only species smaller
than the size of the ﬁlter opening are allowed to diﬀuse
downward and thus interact with the guided light, as illustrated
in Figure 2a. The small dimension prevents cells clogging the
ﬁlter. The nanoﬁlters are aligned parallel to the light
propagation direction without interruption to enable the wave
propagation without diﬀraction and scattering. The cladding
layer on top of grating couplers is not structured in order to
prevent coupling conditions being inﬂuenced by changes of
refractive index (RI) in the liquid sample. According to
Lambert−Beer’s law, we determined the sensitivity S in our
system with relation to other parameters of the sensor as
follows (derivation in Supporting Information)
ηε=S l (1)
where η denotes the mode-ﬁeld overlap with the analyte.31 η is
deﬁned as the energy ratio of the evanescent ﬁeld interacting
with the liquid to the total energy ﬂow. ε is the extinction
coeﬃcient of the detection target; l the length of the light/
sample interaction. If the length of the sensor is ﬁxed by a given
speciﬁcation, the mode-ﬁeld overlap becomes the major
optimization parameter. Mode analysis was performed using
COMSOL Multiphysics to optimize the mode-ﬁeld overlap and
thus the sensitivity (rf. Materials and Methods). Mode analysis
of the fabricated ridge waveguide is shown in Figure 2b, where
transverse electric (TE) and transverse magnetic (TM) modes
indicate horizontal and vertical electrical ﬁeld distribution,
respectively. In this conﬁguration, the TM mode shows higher
mode-ﬁeld overlap than the TE mode, as Figure 2b (right
panel) depicts. The height of the ﬁlter and the thickness of the
waveguide were swept in simulation for sensitivity optimization.
In Figure 2c, the mode-ﬁeld overlap ratio of the TE mode is
plotted. With decreasing waveguide thickness, the overlap ratio
increases because of less conﬁnement. On the other hand, with
larger thickness, the waveguide supports the guiding of higher-
Figure 1. (a) Illustration of the hemolysis sensor comprising
waveguide, cladding, and nanoﬁlter for cell/plasma separation.
Gratings functioning as dispersive element enable spectral analysis
with a line camera as readout. (b) Reference absorption spectra of
main components in blood plasma: Hb, bilirubin, and lipids. The
wavelength of LED light used is highlighted at the background. (c)
Portable setup attached to a state-of-the-art blood gas analyzer for
automatized measurements.
Figure 2. (a) Illustration of the working principle of the waveguide sensor with nanoﬁlters. Large components in blood like cells and platelets are
blocked out of the evanescent ﬁeld of the waveguide. Small molecules like Hb are measured with evanescent absorption spectroscopically. (b) Mode
analysis simulation (electrical ﬁeld norm) of the fabricated waveguide. Diﬀerent waveguide layers are illustrated on the left; TE and TM polarizations
are shown with their ﬁeld distribution on the right. (c) Evanescent overlap ratio with TE polarization for varying ﬁlter height (OrmoComp) and
waveguide thickness (OrmoClear), revealing diﬀerent sensitivities. The desired region with single mode operation is highlighted. (d) Ratio of the
evanescent energy distributed outside the ﬁlter range is plotted agaisnt ﬁlter height (OrmoComp) and waveguide thickness (OrmoClear). The
desired region with <0.5% is highlighted.
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order modes. The border where the ﬁrst order mode occurs is
marked in Figure 2c. The higher order modes were excluded
for their leaky behavior which would compromise data analysis.
The height of the ﬁlters plays an important role in ﬁltration
of the RBCs. The area above the ﬁlters can be accessed by
RBCs causing nonspeciﬁc absorption, and must be minimized.
Figure 2d shows the unﬁltered ratio which is deﬁned as the
proportion of the propagating mode energy ﬂow above the
ﬁlter to the corresponding total energy ﬂow in the liquid. 0.5%
is set to be the threshold, which is derived from the desired Hb
detection limit of 20 mg/dL and the Hb concentration in RBCs
of about 3600 mg/dL. The dividing line shown in Figure 2d
marks the 0.5% limit. The waveguide thickness of 180 nm and
the ﬁlter height of 400 nm were chosen to compromise high
sensitivity and reliable ﬁltration. Our fabricated device (ﬁlter
height 420 nm, ﬁlter width 180 nm, waveguide thickness 190
nm) fairly matches the designed values from the simulation, in
which case the mode-ﬁeld overlap ratio, η is 7.0% (TM) and
6.0% (TE), and a unﬁltered ratio is lower than 0.5%.
The grating couplers have a periodicity of 368 nm to enable
the coupling of broadband light with wavelengths between 405
and 435 nm into the waveguide at an incidence angle of 20−
Figure 3. (a) Illustration of the fabrication steps of the sensor utilizing multiple UV-nanoimprint steps. Fluidic channel is easily deﬁned with taped
channels. (b) Cross-sectional SEM images of nanoﬁlters fabricated on Si in which the ﬁlter height and width can be seen on the bottom panel. The
high uniformity is shown on the top panel. (c) Cross-sectional SEM images of the fabricated waveguide with OrmoComp as ﬁlters, OrmoClear as
waveguide, and Eﬁron as cladding. (d) Fabricated sensor on a glass wafer. (e) Fabricated sensor on a free-standing membrane.
Figure 4. (a) Projection of TE and TM mode on the line camera. (b) Absorption spectra measured with whole blood (WB) and hemolyzed whole
blood (HWB, 50 and 100 mg/dL) samples with TE and TM modes (left). The photospectrometer reference measurements taken with 1 cm cuvettes
are show on the right. (c) Measurements of diﬀerent Hb concentrations in whole blood and plasma. The photospectrometer reference spectra are
scaled and plotted at the background. (d) Absorption spectra of plasma, plasma with 100 mg/dL Hb and their bilirubin-interfered (20 mg/dL)
counterparts. (e) Absorption measured with diﬀerent concentrations of bilirubin mixed into nonhemolyzed plasma.
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28°. There is no lateral conﬁnement in the waveguide, whereas
a width of 2 mm is designed for the grating couplers and the
ﬁlters. The large dimension is chosen deliberately in order to
use commercial LEDs as a light source, which provides
broadband illumination and a large focal spot size. Here, the
broadband light is coupled with diﬀerent incident angles. For a
30 nm bandwidth centered at 420 nm, an incident angle range
of 5.8° is needed to couple the light in, leading to a very low
numerical aperture (i.e., 0.05). The focus is strongly limited
because of the high beam divergence of the commercial
available LED light source. To harvest the maximal energy of
the light source, the angles are matched for coupling with a
single convex lens and the beam size is controlled to be several
millimeters. Note that multilayer gratings can increase the
broadband coupling eﬃciency;9 however, it leads to higher
costs and complexity during fabrication.
Sensor Fabrication and System Integration. The sensor
is fabricated in multiple nanoimprint steps that provide a sub-
200 nm resolution with up-scalable production capacity. Figure
3a shows the entire fabrication sequence. At ﬁrst, a drop-cast
polymer (Eﬁron, Luvantix, South Korea) is imprinted with UV-
curing to deﬁne the grating couplers. A second layer
(OrmoClear H101, micro resist technology GmbH, Germany)
is then spin-coated on top to serve as the core of the waveguide.
The ﬁnal layer featuring the nanoﬁlters (OrmoComp, micro
resist technology GmbH, Germany) is also fabricated with UV-
nanoimprint using an organic−inorganic hybrid polymer stamp
(OrmoStamp, micro resist technology GmbH, Germany). With
the methods developed here, we successfully demonstrated (i)
large scale structural homogeneity up to 6 × 2 mm2, (ii) sub-
200 nm resolution with an aspect ratio (AR) of 2.5, (iii) very
low imprint residual left to the layer underneath, (iv) very low
cost per device, and (v) nearly 100% fabrication yield. The
imprint residualthe thin layer of polymer left on the
supporting substrate after the imprint32must be minimized
because it directly decreases the sensitivity. This is achieved by
introducing an organic−inorganic hybrid polymer mold
replicated from an E-beam written Si stamp. Demonstrations
of the imprinted nanoﬁlters on a Si substrate and on a
waveguide are shown in Figure 3b and c, respectively, where the
imprint residual layer thickness is below 20 nm. The
combination of the materials allows the ﬁnal device to be
ﬂexible and detachable, as the sensor can be simply peeled oﬀ
the glass substrate. The detached, free-standing, and ﬂexible
membrane can be cut into individual sensors, as shown in
Figure 3d and e. This ﬂexibility grants the unique capability of
one-step integration into an existing platforms such as a sensor
cassette containing other sensors. In comparison with other
highly sensitive evanescent sensors,33−38 our sensor can achieve
very short turnaround time (<60 s) with high speciﬁcity toward
Hb in blood plasma. It can measure blood samples with a
variable hematocrit (e.g., from 0% to 45%) and is insusceptible
to any cell clogging. The separation is immediate and
invulnerable to varying ﬂow rate caused by peristaltic pumping,
which is hard to achieve by any microﬂuidic separation
methods.21−24
Sensor Performance. Using the output grating coupler as
the dispersive element, diﬀerent wavelengths can be resolved
from a waveguide by a line camera, as demonstrated by Mendes
et al.9 The use of a single mode waveguide is important because
higher order modes can contaminate the spectrum due to the
diﬀerent out-coupling angles of these modes. In this work, we
used a linear polarizer to distinguish the TE and TM polarized
light because there is around 2° diﬀerence when they are
coupled out of the waveguide. As shown in Figure 4a, the peaks
in the spectra of these two modes deviate in position on the
camera. In the present conﬁguration, both TE and TM modes
are excited by the wide-angle in-coupling. The spectrum on the
camera is determined with two lasers with diﬀerent wavelengths
(details in Supporting Information). To compare with reference
absorption measurements with a photospectrometer, the
spectral sensitivities of the waveguide were taken into account
to correct the line shapes.
We tested the sensor with whole blood (WB), both human
and bovine. The left panel of Figure 4b shows the absorption
spectra of WB and hemolyzed whole blood (HWB) spiked with
50 and 100 mg/dL Hb. The concentration of 100 mg/dL is an
important threshold as it causes about +7% and −24%
interference in clinically relevant K+ and total bilirubin
concentration in the blood, respectively.39 These limits are
also close to the values of the allowable errors recommended by
Clinical Laboratory Improvement Amendments.40 As shown in
Figure 4b, the diﬀerence between 0, 50, and 100 mg/dL is
highly distinctive in both TE and TM polarized incidences,
which conﬁrms that the sensitivity is suﬃciently high. The
maximum of the absorption is visible at 415 nm, in good
agreement with the line shape of the photospectrometer
reference measurements shown on the right panel.
Figure 4c shows the measurements of WB samples (red line)
and their plasma counterparts (blue line) as well as the
photospectrometer reference measurements with 1 cm cuvettes
(gray dashed line), where the latter is scaled in amplitude for
comparison. The maximum Hb concentration used is 200 mg/
dL, which corresponds to about 0.7% hemolysisclose to the
level recommended by European Directorate for the Quality of
Medicines (EDQM) for maximum acceptable level of
hemolysis in blood products for transfusion.41 Each data
point is based on three measurements. At 0 and 100 mg/dL Hb
concentrations, the coeﬃcients of variation (CoV) are 1.65%
and 0.86%, respectively, showing excellent repeatability of the
sensor. Although for the clinical use the hemolysis level from 0
to 200 mg/dL is the most interesting range, the present sensor
can perform in larger extent ranging from 0 to 1000 mg/dL. On
the other hand, comparing the whole blood and plasma
measurements, we observed very good overlaps which shows
that ﬁltration is highly eﬀective. The absorbance of the WB
samples is slightly higher than that of the plasma, which can be
attributed to the unspeciﬁc scattering of the light which can be
absorbed by RBCs in the bulk.
In ﬁeld applications, however, whole blood can be more
complex than just hemoglobin in free plasma. There, the
presence of bilirubin is a main source of interference. We
examined the interference by adding high concentration of
bilirubin into the hemolyzed and nonhemolyzed plasma
samples. 20 mg/dL (corresponding to 340 mmol/L) bilirubin
was added, which is a threshold for neonatal hyper-
bilirubinaemia that can lead to neurological dysfunction.42 As
Figure 4d shows, the bilirubin addition increases the absorption
for both the sensor and reference measurements. However, the
exact amount of Hb and bilirubin can be determined by
multivariate regression with the reference spectra. The addition
of high concentration bilirubin can increase the overall
sensitivity by 18%, which is consistent throughout the
measurements over long period and thus can be calibrated.
The sensitivity shift is caused by two factors: ﬁrst, the large
diﬀerence in molecular weight of Hb and bilirubin, which are
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16 kDa and 0.58−0.76 kDa (unconjugated and conjugated),
respectively. The small protein can access the waveguide
surface more easily, to which albumin is bound, owing to its
high aﬃnity. We observed the same with tartrazine dye solution
(534 g/mol). Second, 99.9% of unconjugated bilirubin is bound
to albumin in the plasma,43 while plasma albumin also adheres
to the sensor surface, where the evanescent ﬁeld is strongest.
Diﬀerent bilirubin concentration mixed into plasma was
measured without hemolysis as shown in Figure 4e. Here, we
observed no change in the sensitivity in high concentration
range, which shows that the change of bilirubin/albumin
binding ratio in high concentration is not relevant.44 Other
nonspeciﬁc binding to the sensor surface is not critical for two
reasons: (1) The sensor surface is passivated by albumin from
the blood plasma. (2) As far as a molecule not absorbing
signiﬁcantly in the 400−430 nm range, it will not interfere with
our absorption measurement, since we analyze the absorption
ﬁngerprint of a molecule rather than the refractive index
change. In summary, we showed the capability of detecting Hb
on whole blood and distinguishing bilirubin as interference with
a single LED light source. However, additional LEDs with
diﬀerent wavelengths can also be integrated to yield a broader
spectrum for other applications.
Long-Term Performance. One of the most important
features for the hemolysis sensor is the long-term performance.
We tested our optical hemolysis sensor rigorously for 7 weeks
with a weekly repetition of the test series, while the sensor was
integrated as an inline component in the modiﬁed ABL90
FLEX blood gas analyzer. A single measurement ﬂow is shown
in Figure 5a, where we see the drop of the signal due to the
absorption of plasma hemoglobin and its fast recovery after the
rinse. The spectra at three diﬀerent time points are shown in
Figure 5b, where no drift or remaining absorbency can be
observed.
A daily test protocol is shown in Figure 5c, where it starts
and terminates with a 450 mg/L tartrazine dye solution for
calibration of the sensitivity. As fresh bovine blood is used for
the preparation of the rest of the reagents, ﬂuctuations in Hb
concentration are inevitable and the dye calibration can thus
better quantify the long-term change. Hemolyzed whole blood
samples with about 100 mg/dL Hb concentration (HWB100)
are tested with 5 runs, followed by its centrifuged plasma
counterparts (plasma100). WB and its plasma counterpart
(plasma) are prepared in the same way. To test for interference,
bilirubin (20 mg/dL) is mixed into the plasma sample with 100
mg/dL Hb. According to Figure 5c, very little change in
sensitivity happens before and after carrying out the measure-
ment series as tartrazine deviates only 0.4%. Very small
concentrations of Hb around 10 mg/dL in nonhemolyzed
samples can be resolved. Only slight deviation is present under
high bilirubin concentration.
Observing the whole test period of 47 days, we can ﬁnd a
high daily repeatability and a small drift in the sensitivity, as
shown in Figure 5d, where the tartrazine absorption is shown.
The results show only a overall drift is 4.7% after 47 days, which
can be attributed to detachment of the nanoﬁlters or slight
change in material optical property as the sensor is kept in
liquid (even in the standby phase). The results of HWB and the
plasma counterparts are plotted in Figure 5e. Variation in
sample Hb concentration is present as the reference Hb
measurements ﬂuctuate between 68 to 115 mg/dL, which helps
evaluating the sensor performance upon concentration
variations. The pooled standard deviations (Sp) are 2.6 and
2.3 mg/dL for whole blood and plasma samples, respectively,
showing similar and very good repeatability. From these values,
we can calculate the limit of detection to be 4.3 mg/dL for free
hemoglobin sensing in whole blood. Note that the bias to the
reference is not considered. The bias between WB and plasma
samples is however larger (up to 10%). It might originate from
the scattered light, which is not guided but still projected onto
the camera, and the camera background correction that took
place between the HWB and plasma measurements.
Figure 5. (a) Time-resolved absorption signal at 420 nm wavelength for measurement of hemolyzed whole blood (HWB) with 100 mg/dL Hb.
Diﬀerent sections of the measurements are highlighted and annotated. (b) Spectral information during a measurement for buﬀer signal at 0 and 60 s
and HWB at 18 s. (c) Measurement protocol on 47th measurement day. The values from our sensor are annotated on top and to be compared with
references. (d) Sensitivity development with tartrazine calibration liquid for 47 days. (e) Comparison of hemolyzed whole blood (Hb 100 mg/dL,
HWB100) and their plasma counterparts (plasma100) together with reference values.(f) Comparison of hemolyzed whole blood (100 mg/dL Hb)
with bilirubin addition (bil.+pls100) with reference values of the Hb concentration.
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Furthermore, the inﬂuence of additional bilirubin in plasma is
evaluated. Figure 5f shows the evaluated Hb in plasma with
bilirubin interference; the Sp of 2.7 mg/dL is almost the same as
that without bilirubin. An overall positive bias with respect to
the reference (7.0% CoV in average) can be seen, indicating
slightly elevated absorption with the coexistence of bilirubin
and Hb. In general, we observed no performance deterioration
after 7 weeks, conﬁrming the durability of the hemolysis sensor
with the long-term exposure to blood and rinse.
■ CONCLUSIONS
In summary, we demonstrated an optoﬂuidic waveguide sensor
for in-line hemolysis detection on whole blood with unique,
integrated cell/plasma separation ability. The arrangement of
nanoﬁlters on top of the waveguide enables local blocking of
species out of the evanescent ﬁeld and allows independent
choice of light wavelength and ﬁltration size. The fabrication
process can be easily scaled up for industrial production with
low cost and high production yield. The sensor can be used as a
ﬂexible, standalone device or can be easily integrated into
existing PoC platforms. It is shown that a spectrometer-less
analysis of spectral extinction of molecules can be successfully
achieved by employing out-coupling gratings as a dispersive
element and a line camera for readout. We demonstrate here
that the portable optical setup is capable of being integrated
into a commercial blood gas analyzer. Long-term tests up to 7
weeks were also carried out to demonstrate the high
repeatability and reliability of the hemolysis sensor subject to
whole blood samples even with the presence of strong
interference from bilirubin. We envisage large potential for
the sensor to be used inline in blood gas analyzers for hemolysis
detection as well as in other ﬁelds related to turbid media
measurements.
■ MATERIALS AND METHODS
Sensor Fabrication and Materials. To fabricate the hemolysis
sensor, a boroﬂoat wafer was used as substrate a substrate. The
polymer Eﬁron (Luvantix, South Korea) was drop-cast and imprinted
with the silicon master stamp, which is treated with perﬂuorodecyltri-
chlorosilane (FTDS). The polymer was cured by UV exposure in an
N2 atmosphere, followed by manual separation with a razor blade. The
waveguide layer made of OrmoClear H101 was spin-coated on the
Eifron surface treated with oxygen plasma and baked to evaporate
solvent. OrmoClear H101 was diluted with propylene glycol methyl
ether acetate (PGMEA) to yield the desired thickness. The UV curing
of OrmoClear H101 was done by UV curing in N2 atmosphere. The
waveguide stack was oxygen plasma treated before spin-coating with
OrmoComp, which was diluted in the same way as OrmoClear H101.
After the evaporation of the solvent, the waveguide was aligned with
the organic−inorganic hybrid imprint stamp to deﬁne the nanoﬁlters.
Imprinting was done by applying 6 bar pressure for 20 min with
subsequent UV exposure in a UV-imprinter (CNI v 2.0, NIL
Technology, Denmark). A thick layer of OrmoComp can be optionally
used to passivate the surface outside of the ﬁlter region, which was
done with UV-photolithography with a mask aligner (Karl Süss MA6
contact aligner, Germany). Finally, a ﬂuidic channel can be applied by
a double-adhesive tape (tesa 62571, Germany) with a cover formed by
laser-cut PMMA. Fabrication of the organic−inorganic hybrid imprint
stamp started with oxygen plasma treatment of a boroﬂoat glass wafer,
followed by spin-coating of an adhesion layer OrmoPrime08. Around
150 μL OrmoStamp was suspended on top of the wafer and imprinted
with the FTDS-treated master stamp while UV exposure was applied
to cure the OrmoStamp, followed by hard-baking at 130 °C for 15
min. The stamp was ﬁnished by treating with FTDS for antisticking
property. Here, OrmoPrime08, OrmoStamp, OrmoClear H101,
OrmoComp, PGMEA are acquired from micro resist technology
GmbH, Germany.
Optical Simulations. The mode analysis simulations were carried
out with COMSOL (COMSOL Multiphysics). Unit cells were deﬁned
with Floquet periodicity. Real and imaginary refractive index were
acquired by spectroscopic ellipsometry measurements (M-2000, J.A.
Woollam) of each material deposited as a thin ﬁlm onto silicon wafers.
OrmoComp (nOrmoComp = 1.537 @420 nm), OrmoClear H101
(nOrmoClear = 1.629 @420 nm), and Eﬁron (nOrmoComp = 1.414 @420
nm) were modeled for the geometry we obtained. The evanescent
overlap was deﬁned by the ratio of power immersed in the liquid to
the total power in the waveguide. Unﬁltered ratio was deﬁned as
power in the area higher than the top of the ﬁlter region to the total
power in the liquid.
Blood Sample Preparation. Hemolyzed whole blood was
prepared by mixing completely hemolyzed fresh whole blood from
human or bovine to fresh whole blood, of which the total hemoglobin
concentration was measured with a blood gas analyzer in advance
(ABL90 FLEX, Radiometer Aps, Denmark). The completely
hemolyzed whole blood was obtained by freezing the blood sample
in −20 °C for at least 3 h. Part of the prepared whole blood sample
was centrifuged to obtain the plasma sample. Bilirubin interfered
plasma samples were prepared by adding concentrated bilirubin base
solution into plasma from the centrifuged whole blood sample
containing 100 mg/dL Hb. The bilirubin base solution was prepared
by mixing bilirubin powder (Sigma-Aldrich, USA) into 0.1 M NaOH
solution with a concentration of 10 g/L. Tartrazine calibration liquid
was prepared by mixing tartrzine (450 mg/L) into the Cal. Two
solution from a Radiometer solution pack (REF 944−157, Radiometer
Aps, Denmark).
Absorption Characterization. An LED light source (M420L3,
Thorlabs) with a peak wavelength of 420 nm was used for the Hb
absorption test. The light was collimated into a multimode ﬁber with a
core diameter of 200 μm. The output light was collimated and focused
with a plano-convex lens with a focal length of 50 mm. The sensor was
placed on a platform with two apertures ﬁtting the size of the grating
couplers (2 × 2 mm). The out-coupled light was ﬁltered through a
linear polarizer and captured by a CMOS linear image sensor
(S11639−01, Hamamatsu, Japan). For the calibration of the sensor,
405 and 450 nm laser diode modules (CPS405, CPS450, Thorlabs)
were used to deﬁne the spectral locations. During the measurement
phosphate buﬀered saline (PBS) or rinse solution from Radiometer
solution pack (REF 944−157, Radiometer ApS, Denmark) were used
to rinse the surface of the sensor. Scattering signals on the linear
camera were corrected by linear subtraction of signal tails before the
absorbance is calculated.
Reference Absorption Measurement. All biological samples
were diluted with phosphate buﬀered saline (PBS) solution according
to their concentrations. The following mixing ratios were used for
samples in this work: nonhemolyzed plasma 1:3, plasma with 100 mg/
dL Hb 1:6, plasma with 100 mg/dL Hb and 20 mg/dL bilirubin 1:12,
tartrazine calibration solution with 450 mg/L tartrazine: 1:12. UV-
transparent 1 cm cuvettes were used for characterization with a UV
photospectrometer (UV-1800 Shimadzu Corp., Japan). A spectral
range from 330 to 700 nm was used to characterize the samples for
reference.
Long-Term Measurement. During the long-term measurements
the optical setup was attached to a modiﬁed ABL90 FLEEX blood gas
analyzer(Radiometer ApS, Denmark). Two ports were wired through
silicone tubing to the in- and outlet of the analyzer. The samples were
always acquired through the sample inlet of the analyzer. Each
acquisition took around 70 μL of the sample, which was delivered to
the sensor by the internal peristaltic pump of the analyzer. Five
seconds were set to allow the sample in touch with the sensor before
the rinse protocol is carried out, which was a modiﬁed version of the
commercial version of the analyzer, including 5 times air and rinse
alternating purge and a ﬁnal liquid rinse. Recording of the camera was
carried out with 2−12 ms integration time subject to the intensity
transmitted. 250 ms sampling interval was used for real-time recording,
which terminated after 20 s after the rinse protocol. The calculation of
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the diﬀerent components in the blood was made afterward by
nonlinear least-squares ﬁtting with reference spectra. Daily measure-
ment protocol included 5 times repeated HWB 100 and the rest
samples were measured 3 times apart from the tartrazine calibration
liquid which was measured once before and after all other
measurements. Tartrazine (450 mg/dL) was measured once before
and once after the blood and plasma measurements. The evaluation of
the long-term sensitivity change was done by observing tartrazine
absorption over days, while it was calibrated with the measurements on
the ﬁrst day to 450 mg/dL. Bovine blood was used during the long-
term test, which was acquired from Statens Serum Institute, Denmark.
After the sample measurements, the analyzer was automated to
perform a rinse protocol every 4 h for circulation and purge.
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